Cargando…
Relevance of tumor boards for the inclusion of patients in oncological clinical trials
INTRODUCTION: Major national and international oncological societies generally recommend treating a significant proportion of oncological patients in clinical trials to improve therapy strategies for cancer patients. At cancer centers, the recommendation about the appropriate therapy for the individ...
Autores principales: | Dapper, Hendrik, Dantes, Maurice, Herschbach, Peter, Algül, Hana, Heinemann, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374816/ https://www.ncbi.nlm.nih.gov/pubmed/36995407 http://dx.doi.org/10.1007/s00432-022-04559-0 |
Ejemplares similares
-
Implementing precision oncology for sarcoma patients: the CCC(LMU)molecular tumor board experience
por: Berclaz, Luc M., et al.
Publicado: (2023) -
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich(LMU) Molecular Tumor Board
por: Dorman, Klara, et al.
Publicado: (2023) -
Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey
por: Schäfer, Niklas, et al.
Publicado: (2021) -
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
por: Tamborero, David, et al.
Publicado: (2022) -
Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the Neuroradiologist
por: Gaudino, Simona, et al.
Publicado: (2022)